+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Iron Deficiency Anemia Therapy Market Size, Share & Trends Analysis Report By Therapy Type (Oral Iron Therapy, Parenteral Iron Therapy), By Age Group, By End-user, By Region, And Segment Forecasts, 2023 - 2030

  • PDF Icon

    Report

  • 120 Pages
  • September 2023
  • Region: Global
  • Grand View Research
  • ID: 5893101
Description Jump to:
The global iron deficiency anemia therapy market size is expected to reach USD 8.06 billion by 2030. The market is projected to grow at a CAGR of 7.6% from 2023 to 2030. Rising cases of abnormally heavy bleeding during menstruation and post-partum hemorrhage are some major factors increasing the adoption rate of IDA therapy in young women. Moreover, rising awareness for women's nutritional health, advancing parenteral nutrition supplements, and novel product launches are some key drivers fueling the market growth for iron deficiency anemia (IDA) therapy.

According to a National Library of Medicine report updated in March 2023, the annual prevalence of menorrhagia is 53 per 1, 000 women. Another article published by the National Library of Medicine in June 2018 states that menstrual disorders such as menorrhagia (heavy menstrual blood loss) contribute to approximately 5-10% of cases of IDA in the perimenopausal age group. Moreover, in developing countries where nutritional iron deficiency is already prevalent among perimenopausal women, menorrhagia is an exacerbating factor, leading to severe anemia.

Rising awareness among people and strategic initiatives by regional governments for women's nutritional health, advancing parenteral nutrition supplements, and novel product launches are some of the key driving factors for the global IDA therapy market growth. For instance, in February 2023, in India, the Kerala state government launched its initiative in addition to the Centre's Anaemia Mukt Bharat program. The campaign aimed to reach around 13 million women across the state within six months. A door-to-door campaign was conducted to test and implement graded interventions to reduce the burden of anemia.

Industry leaders are involved in collaborations & acquisitions to enhance their product portfolios. For instance, in November 2022, CSL Vifor and Fresenius Kabi announced that Ferinject, an intravenous iron therapy, had received approval from China's NMPA for treating iron deficiency in adult patients. Ferinject is indicated for cases where oral preparations are ineffective or unsuitable or when rapid iron delivery is clinically necessary. At the time, the companies planned to commence marketing Ferinject in the first half of 2023, with the approval marking its marketing authorization in 85 countries, along with an anticipated NRDL listing in January 2024. This represents an opportunity for enhanced market presence and expanded patient access to Ferinject globally. Similarly, in July 2021, Sandoz launched a cost-effective Ferumoxytol injection, the first generic intravenous high-dosage iron for treating IDA in the U.S.

Iron Deficiency Anemia Therapy Market Report Highlights

  • The growth of the overall IDA therapy market is attributed to the increasing prevalence of anemia associated with iron deficiency across the globe
  • The market is witnessing a key shift with the rise in preference for home healthcare settings, which is especially appealing to those with chronic or less severe cases of iron deficiency anemia
  • Parenteral iron therapy held the largest share in terms of therapy type in 2022. This is owing to the advancements in parenteral iron formulations and new product launches by key companies operating in the market
  • The adult age group segment held the largest revenue share of 63.87% in 2022. This is attributed to busy lifestyles and improper diets contributing to the extensive prevalence of iron deficiency anemia in adults
  • North America dominated the market in 2022, owing to the presence of several key players and rising support from governments for overcoming the burden of IDA in the region
  • Key players in the market are adopting strategies such as new product launches, partnerships, and collaborations, among others to expand their global geographical reach

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation And Scope
1.1.1. Segment Definitions
1.1.1.1. Therapy Type Segment
1.1.1.2. Age Group Segment
1.1.1.3. End-User Segment
1.2. Regional Scope
1.3. Estimates And Forecast Timeline
1.4. Objectives
1.4.1. Objective - 1
1.4.2. Objective - 2
1.4.3. Objective - 3
1.5. Research Methodology
1.6. Information Or Data Analysis
1.7. Market Model
1.7.1. Commodity Flow Analysis
1.8. List Of Secondary Sources
1.9. List Of Abbreviations
Chapter 2. Executive Summary
2.1. Market Snapshot
2.2. Therapy Type and Age Group Snapshot
2.3. End-user Snapshot
2.4. Competitive Landscape Snapshot
Chapter 3. Market Variables, Trends, & Scope
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Related/Ancillary Market Outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.1.1. Increasing global elderly population
3.2.1.2. Increasing prevalence of iron deficiency anemia
3.2.1.3. Growing government initiatives to overcome the burden of iron deficiency
3.2.2. Market Restraint Analysis
3.2.2.1. Side effects associated with certain IDA therapies
3.3. Industry Analysis Tools
3.3.1. Porter’s Five Forces Analysis
3.3.2. PESTEL Analysis
3.3.3. COVID-19 Impact Analysis
Chapter 4. Therapy Type Business Analysis
4.1. Iron Deficiency Anemia Therapy Market: Therapy Type Movement Analysis
4.2. Oral Iron Therapy
4.2.1. Oral Iron Therapy Market, 2018 - 2030 (USD Million)
4.3. Parenteral Iron Therapy
4.3.1. Parenteral Iron Therapy Market, 2018 - 2030 (USD Million)
4.4. Red Blood Cell Transfusion
4.4.1. Red Blood Cell Transfusion Market, 2018 - 2030 (USD Million)
4.5. Others
4.5.1. Others Market, 2018 - 2030 (USD Million)
Chapter 5. Age Group Business Analysis
5.1. Iron Deficiency Anemia Therapy Market: Age Group Movement Analysis
5.2. Adults
5.2.1. Adults Market, 2018 - 2030 (USD Million)
5.3. Pediatric
5.3.1. Pediatric Market, 2018 - 2030 (USD Million)
5.4. Geriatric
5.4.1. Geriatric Market, 2018 - 2030 (USD Million)
Chapter 6. End-User Business Analysis
6.1. Iron Deficiency Anemia Therapy Market: End-User Movement Analysis
6.2. Clinics
6.2.1. Clinics Market, 2018 - 2030 (USD Million)
6.3. Hospitals
6.3.1. Hospitals Market, 2018 - 2030 (USD Million)
6.4. Home Healthcare
6.4.1. Home Healthcare Market, 2018 - 2030 (USD Million)
Chapter 7. Regional Business Analysis
7.1. Iron Deficiency Anemia Therapy Market Share By Region, 2022 & 2030
7.2. North America
7.2.1. SWOT Analysis
7.2.2. North America Iron Deficiency Anemia Therapy Market, 2018 - 2030 (USD Million)
7.2.3. U.S.
7.2.3.1. Key Country Dynamics
7.2.3.2. Target Disease Prevalence
7.2.3.3. Competitive Scenario
7.2.3.4. Regulatory Framework
7.2.3.5. U.S. Iron Deficiency Anemia Therapy Market, 2018 - 2030 (USD Million)
7.2.4. Canada
7.2.4.1. Key Country Dynamics
7.2.4.2. Target Disease Prevalence
7.2.4.3. Competitive Scenario
7.2.4.4. Regulatory Framework
7.2.4.5. Canada Iron Deficiency Anemia Therapy Market, 2018 - 2030 (USD Million)
7.3. Europe
7.3.1. Europe Iron Deficiency Anemia Therapy Market, 2018 - 2030 (USD Million)
7.3.2. UK
7.3.2.1. Key Country Dynamics
7.3.2.2. Target Disease Prevalence
7.3.2.3. Competitive Scenario
7.3.2.4. Regulatory Framework
7.3.2.5. UK Iron Deficiency Anemia Therapy Market, 2018 - 2030 (USD Million)
7.3.3. Germany
7.3.3.1. Key Country Dynamics
7.3.3.2. Target Disease Prevalence
7.3.3.3. Competitive Scenario
7.3.3.4. Regulatory Framework
7.3.3.5. Germany Iron Deficiency Anemia Therapy Market, 2018 - 2030 (USD Million)
7.3.4. France
7.3.4.1. Key Country Dynamics
7.3.4.2. Target Disease Prevalence
7.3.4.3. Competitive Scenario
7.3.4.4. Regulatory Framework
7.3.4.5. France Iron Deficiency Anemia Therapy Market, 2018 - 2030 (USD Million)
7.3.5. Italy
7.3.5.1. Key Country Dynamics
7.3.5.2. Target Disease Prevalence
7.3.5.3. Competitive Scenario
7.3.5.4. Regulatory Framework
7.3.5.5. Italy Iron Deficiency Anemia Therapy Market, 2018 - 2030 (USD Million)
7.3.6. Spain
7.3.6.1. Key Country Dynamics
7.3.6.2. Target Disease Prevalence
7.3.6.3. Competitive Scenario
7.3.6.4. Regulatory Framework
7.3.6.5. Spain Iron Deficiency Anemia Therapy Market, 2018 - 2030 (USD Million)
7.3.7. Denmark
7.3.7.1. Key Country Dynamics
7.3.7.2. Target Disease Prevalence
7.3.7.3. Competitive Scenario
7.3.7.4. Regulatory Framework
7.3.7.5. Denmark Iron Deficiency Anemia Therapy Market, 2018 - 2030 (USD Million)
7.3.8. Sweden
7.3.8.1. Key Country Dynamics
7.3.8.2. Target Disease Prevalence
7.3.8.3. Competitive Scenario
7.3.8.4. Regulatory Framework
7.3.8.5. Sweden Iron Deficiency Anemia Therapy Market, 2018 - 2030 (USD Million)
7.3.9. Norway
7.3.9.1. Key Country Dynamics
7.3.9.2. Target Disease Prevalence
7.3.9.3. Competitive Scenario
7.3.9.4. Regulatory Framework
7.3.9.5. Norway Iron Deficiency Anemia Therapy Market, 2018 - 2030 (USD Million)
7.4. Asia Pacific
7.4.1. Asia Pacific Iron Deficiency Anemia Therapy Market, 2018 - 2030 (USD Million)
7.4.2. Japan
7.4.2.1. Key Country Dynamics
7.4.2.2. Target Disease Prevalence
7.4.2.3. Competitive Scenario
7.4.2.4. Regulatory Framework
7.4.2.5. Japan Iron Deficiency Anemia Therapy Market, 2018 - 2030 (USD Million)
7.4.3. China
7.4.3.1. Key Country Dynamics
7.4.3.2. Target Disease Prevalence
7.4.3.3. Competitive Scenario
7.4.3.4. Regulatory Framework
7.4.3.5. China Iron Deficiency Anemia Therapy Market, 2018 - 2030 (USD Million)
7.4.4. India
7.4.4.1. Key Country Dynamics
7.4.4.2. Target Disease Prevalence
7.4.4.3. Competitive Scenario
7.4.4.4. Regulatory Framework
7.4.4.5. India Iron Deficiency Anemia Therapy Market, 2018 - 2030 (USD Million)
7.4.5. Australia
7.4.5.1. Key Country Dynamics
7.4.5.2. Target Disease Prevalence
7.4.5.3. Competitive Scenario
7.4.5.4. Regulatory Framework
7.4.5.5. Australia Iron Deficiency Anemia Therapy Market, 2018 - 2030 (USD Million)
7.4.6. Thailand
7.4.6.1. Key Country Dynamics
7.4.6.2. Target Disease Prevalence
7.4.6.3. Competitive Scenario
7.4.6.4. Regulatory Framework
7.4.6.5. Thailand Iron Deficiency Anemia Therapy Market, 2018 - 2030 (USD Million)
7.4.7. South Korea
7.4.7.1. Key Country Dynamics
7.4.7.2. Target Disease Prevalence
7.4.7.3. Competitive Scenario
7.4.7.4. Regulatory Framework
7.4.7.5. South Korea Iron Deficiency Anemia Therapy Market, 2018 - 2030 (USD Million)
7.5. Latin America
7.5.1. Latin America Iron Deficiency Anemia Therapy Market, 2018 - 2030 (USD Million)
7.5.2. Brazil
7.5.2.1. Key Country Dynamics
7.5.2.2. Target Disease Prevalence
7.5.2.3. Competitive Scenario
7.5.2.4. Regulatory Framework
7.5.2.5. Brazil Iron Deficiency Anemia Therapy Market, 2018 - 2030 (USD Million)
7.5.3. Mexico
7.5.3.1. Key Country Dynamics
7.5.3.2. Target Disease Prevalence
7.5.3.3. Competitive Scenario
7.5.3.4. Regulatory Framework
7.5.3.5. Mexico Iron Deficiency Anemia Therapy Market, 2018 - 2030 (USD Million)
7.5.4. Argentina
7.5.4.1. Key Country Dynamics
7.5.4.2. Target Disease Prevalence
7.5.4.3. Competitive Scenario
7.5.4.4. Regulatory Framework
7.5.4.5. Argentina Iron Deficiency Anemia Therapy Market, 2018 - 2030 (USD Million)
7.6. MEA
7.6.1. MEA Iron Deficiency Anemia Therapy Market, 2018 - 2030 (USD Million)
7.6.2. South Africa
7.6.2.1. Key Country Dynamics
7.6.2.2. Target Disease Prevalence
7.6.2.3. Competitive Scenario
7.6.2.4. Regulatory Framework
7.6.2.5. South Africa Iron Deficiency Anemia Therapy Market, 2018 - 2030 (USD Million)
7.6.3. Saudi Arabia
7.6.3.1. Key Country Dynamics
7.6.3.2. Target Disease Prevalence
7.6.3.3. Competitive Scenario
7.6.3.4. Regulatory Framework
7.6.3.5. Saudi Arabia Iron Deficiency Anemia Therapy Market, 2018 - 2030 (USD Million)
7.6.4. UAE
7.6.4.1. Key Country Dynamics
7.6.4.2. Target Disease Prevalence
7.6.4.3. Competitive Scenario
7.6.4.4. Regulatory Framework
7.6.4.5. UAE Iron Deficiency Anemia Therapy Market, 2018 - 2030 (USD Million)
7.6.5. Kuwait
7.6.5.1. Key Country Dynamics
7.6.5.2. Target Disease Prevalence
7.6.5.3. Competitive Scenario
7.6.5.4. Regulatory Framework
7.6.5.5. Kuwait Iron Deficiency Anemia Therapy Market, 2018 - 2030 (USD Million)
Chapter 8. Competitive Landscape
8.1. Participant Categorization
8.2. Strategy Mapping
8.2.1. New Product Launch
8.2.2. Partnerships
8.2.3. Collaboration
8.3. Key Company Market Share Analysis, 2022
8.4. Company Profiles
8.4.1. Akebia Therapeutics, Inc.
8.4.1.1. Overview
8.4.1.2. Financial Performance
8.4.1.3. Product Benchmarking
8.4.1.4. Strategic Initiatives
8.4.2. Bayer AG
8.4.2.1. Overview
8.4.2.2. Financial Performance
8.4.2.3. Product Benchmarking
8.4.2.4. Strategic Initiatives
8.4.3. PHARMACOSMOS A/S
8.4.3.1. Overview
8.4.3.2. Financial Performance
8.4.3.3. Product Benchmarking
8.4.3.4. Strategic Initiatives
8.4.4. Sanofi
8.4.4.1. Overview
8.4.4.2. Financial Performance
8.4.4.3. Product Benchmarking
8.4.4.4. Strategic Initiatives
8.4.5. Johnson & Johnson Services, Inc.
8.4.5.1. Overview
8.4.5.2. Financial Performance
8.4.5.3. Product Benchmarking
8.4.5.4. Strategic Initiatives
8.4.6. CSL Vifor
8.4.6.1. Overview
8.4.6.2. Financial Performance
8.4.6.3. Product Benchmarking
8.4.6.4. Strategic Initiatives
8.4.7. AbbVie Inc. (Allergan)
8.4.7.1. Overview
8.4.7.2. Financial Performance
8.4.7.3. Product Benchmarking
8.4.7.4. Strategic Initiatives
8.4.8. Novartis AG
8.4.8.1. Overview
8.4.8.2. Financial Performance
8.4.8.3. Product Benchmarking
8.4.8.4. Strategic Initiatives
8.4.9. Teoxane
8.4.9.1. Overview
8.4.9.2. Financial Performance
8.4.9.3. Product Benchmarking
8.4.9.4. Strategic Initiatives
8.4.10. Zydus Group
8.4.10.1. Overview
8.4.10.2. Financial Performance
8.4.10.3. Product Benchmarking
8.4.10.4. Strategic Initiatives
8.4.11. GSK plc
8.4.11.1. Overview
8.4.11.2. Financial Performance
8.4.11.3. Product Benchmarking
8.4.11.4. Strategic Initiatives
8.4.12. AdvaCare Pharma
8.4.12.1. Overview
8.4.12.2. Financial Performance
8.4.12.3. Product Benchmarking
8.4.12.4. Strategic Initiatives
8.4.13. Apotex Inc.
8.4.13.1. Overview
8.4.13.2. Financial Performance
8.4.13.3. Product Benchmarking
8.4.13.4. Strategic Initiatives
8.4.14. Covis Pharma GmbH
8.4.14.1. Overview
8.4.14.2. Financial Performance
8.4.14.3. Product Benchmarking
8.4.14.4. Strategic Initiatives
List of Tables
Table 1 List of secondary sources
Table 2 List of abbreviations
Table 3 Global Iron Deficiency Anemia Therapy Market, By Therapy Type, 2018 - 2030 (USD Million)
Table 4 Global Iron Deficiency Anemia Therapy Market, By Age Group, 2018 - 2030 (USD Million)
Table 5 Global Iron Deficiency Anemia Therapy Market, By End-User, 2018 - 2030 (USD Million)
Table 6 Global Iron Deficiency Anemia Therapy Market, By Region, 2018 - 2030 (USD Million)
Table 7 North America Iron Deficiency Anemia Therapy Market, By Country, 2018 - 2030 (USD Million)
Table 8 North America Iron Deficiency Anemia Therapy Market, By Therapy Type, 2018 - 2030 (USD Million)
Table 9 North America Iron Deficiency Anemia Therapy Market, By Age Group, 2018 - 2030 (USD Million)
Table 10 North America Iron Deficiency Anemia Therapy market, by End-User, 2018 - 2030 (USD Million)
Table 11 US Iron Deficiency Anemia Therapy market, by Therapy Type, 2018 - 2030 (USD Million)
Table 12 US Iron Deficiency Anemia Therapy Market, By Age Group, 2018 - 2030 (USD Million)
Table 13 US Iron Deficiency Anemia Therapy market, by End-User, 2018 - 2030 (USD Million)
Table 14 Canada Iron Deficiency Anemia Therapy market, by Therapy Type, 2018 - 2030 (USD Million)
Table 15 Canada Iron Deficiency Anemia Therapy Market, By Age Group, 2018 - 2030 (USD Million)
Table 16 Canada Iron Deficiency Anemia Therapy market, by End-User, 2018 - 2030 (USD Million)
Table 17 Europe Iron Deficiency Anemia Therapy market, by Country, 2018 - 2030 (USD Million)
Table 18 Europe Iron Deficiency Anemia Therapy Market, By Age Group, 2018 - 2030 (USD Million)
Table 19 Europe Iron Deficiency Anemia Therapy market, by Therapy Type, 2018 - 2030 (USD Million)
Table 20 Europe Iron Deficiency Anemia Therapy market, by End-User, 2018 - 2030 (USD Million)
Table 21 UK Iron Deficiency Anemia Therapy market, by Therapy Type, 2018 - 2030 (USD Million)
Table 22 UK Iron Deficiency Anemia Therapy Market, By Age Group, 2018 - 2030 (USD Million)
Table 23 UK Iron Deficiency Anemia Therapy market, by End-User, 2018 - 2030 (USD Million)
Table 24 Germany Iron Deficiency Anemia Therapy market, by Therapy Type, 2018 - 2030 (USD Million)
Table 25 Germany Iron Deficiency Anemia Therapy market, by Age Group, 2018 - 2030 (USD Million)
Table 26 Germany Iron Deficiency Anemia Therapy market, by End-User, 2018 - 2030 (USD Million)
Table 27 France Iron Deficiency Anemia Therapy market, by Therapy Type, 2018 - 2030 (USD Million)
Table 28 France Iron Deficiency Anemia Therapy market, by Age Group, 2018 - 2030 (USD Million)
Table 29 France Iron Deficiency Anemia Therapy market, by End-User, 2018 - 2030 (USD Million)
Table 30 Italy Iron Deficiency Anemia Therapy market, by Therapy Type, 2018 - 2030 (USD Million)
Table 31 Italy Iron Deficiency Anemia Therapy market, by Age Group, 2018 - 2030 (USD Million)
Table 32 Italy Iron Deficiency Anemia Therapy market, by End-User, 2018 - 2030 (USD Million)
Table 33 Spain Iron Deficiency Anemia Therapy market, by Therapy Type, 2018 - 2030 (USD Million)
Table 34 Spain Iron Deficiency Anemia Therapy market, by Age Group, 2018 - 2030 (USD Million)
Table 35 Spain Iron Deficiency Anemia Therapy market, by End-User, 2018 - 2030 (USD Million)
Table 36 Denmark Iron Deficiency Anemia Therapy market, by Therapy Type, 2018 - 2030 (USD Million)
Table 37 Denmark Iron Deficiency Anemia Therapy market, by Age Group, 2018 - 2030 (USD Million)
Table 38 Denmark Iron Deficiency Anemia Therapy market, by End-User, 2018 - 2030 (USD Million)
Table 39 Sweden Iron Deficiency Anemia Therapy market, by Therapy Type, 2018 - 2030 (USD Million)
Table 40 Sweden Iron Deficiency Anemia Therapy market, by Age Group, 2018 - 2030 (USD Million)
Table 41 Sweden Iron Deficiency Anemia Therapy market, by End-User, 2018 - 2030 (USD Million)
Table 42 Norway Iron Deficiency Anemia Therapy market, by Therapy Type, 2018 - 2030 (USD Million)
Table 43 Norway Iron Deficiency Anemia Therapy market, by Age Group, 2018 - 2030 (USD Million)
Table 44 Norway Iron Deficiency Anemia Therapy market, by End-User, 2018 - 2030 (USD Million)
Table 45 Asia Pacific Iron Deficiency Anemia Therapy market, by country, 2018 - 2030 (USD Million)
Table 46 Asia Pacific Iron Deficiency Anemia Therapy market, by Therapy Type, 2018 - 2030 (USD Million)
Table 47 Asia Pacific Iron Deficiency Anemia Therapy market, by Age Group, 2018 - 2030 (USD Million)
Table 48 Asia Pacific Iron Deficiency Anemia Therapy market, by End-User, 2018 - 2030 (USD Million)
Table 49 Japan Iron Deficiency Anemia Therapy market, by Therapy Type, 2018 - 2030 (USD Million)
Table 50 Japan Iron Deficiency Anemia Therapy market, by Age Group, 2018 - 2030 (USD Million)
Table 51 Japan Iron Deficiency Anemia Therapy market, by End-User, 2018 - 2030 (USD Million)
Table 52 China Iron Deficiency Anemia Therapy market, by Therapy Type, 2018 - 2030 (USD Million)
Table 53 China Iron Deficiency Anemia Therapy market, by Age Group, 2018 - 2030 (USD Million)
Table 54 China Iron Deficiency Anemia Therapy market, by End-User, 2018 - 2030 (USD Million)
Table 55 India Iron Deficiency Anemia Therapy market, by Therapy Type, 2018 - 2030 (USD Million)
Table 56 India Iron Deficiency Anemia Therapy market, by Age Group, 2018 - 2030 (USD Million)
Table 57 India Iron Deficiency Anemia Therapy market, by End-User, 2018 - 2030 (USD Million)
Table 58 Australia Iron Deficiency Anemia Therapy market, by Therapy Type, 2018 - 2030 (USD Million)
Table 59 Australia Iron Deficiency Anemia Therapy market, by Age Group, 2018 - 2030 (USD Million)
Table 60 Australia Iron Deficiency Anemia Therapy market, by End-User, 2018 - 2030 (USD Million)
Table 61 Thailand Iron Deficiency Anemia Therapy market, by Therapy Type, 2018 - 2030 (USD Million)
Table 62 Thailand Iron Deficiency Anemia Therapy market, by Age Group, 2018 - 2030 (USD Million)
Table 63 Thailand Iron Deficiency Anemia Therapy market, by End-User, 2018 - 2030 (USD Million)
Table 64 South Korea Iron Deficiency Anemia Therapy market, by Therapy Type, 2018 - 2030 (USD Million)
Table 65 South Korea Iron Deficiency Anemia Therapy market, by Age Group, 2018 - 2030 (USD Million)
Table 66 South Korea Iron Deficiency Anemia Therapy market, by End-User, 2018 - 2030 (USD Million)
Table 67 Latin America Iron Deficiency Anemia Therapy market, by country, 2018 - 2030 (USD Million)
Table 68 Latin America Iron Deficiency Anemia Therapy market, by Therapy Type, 2018 - 2030 (USD Million)
Table 69 Latin America Iron Deficiency Anemia Therapy market, by Age Group, 2018 - 2030 (USD Million)
Table 70 Latin America Iron Deficiency Anemia Therapy market, by End-User, 2018 - 2030 (USD Million)
Table 71 Brazil Iron Deficiency Anemia Therapy market, by Therapy Type, 2018 - 2030 (USD Million)
Table 72 Brazil Iron Deficiency Anemia Therapy market, by Age Group, 2018 - 2030 (USD Million)
Table 73 Brazil Iron Deficiency Anemia Therapy market, by End-User, 2018 - 2030 (USD Million)
Table 74 Mexico Iron Deficiency Anemia Therapy market, by Therapy Type, 2018 - 2030 (USD Million)
Table 75 Mexico Iron Deficiency Anemia Therapy market, by Age Group, 2018 - 2030 (USD Million)
Table 76 Mexico Iron Deficiency Anemia Therapy market, by End-User, 2018 - 2030 (USD Million)
Table 77 Argentina Iron Deficiency Anemia Therapy market, by Therapy Type, 2018 - 2030 (USD Million)
Table 78 Argentina Iron Deficiency Anemia Therapy market, by Age Group, 2018 - 2030 (USD Million)
Table 79 Argentina Iron Deficiency Anemia Therapy market, by End-User, 2018 - 2030 (USD Million)
Table 80 Middle East & Africa Iron Deficiency Anemia Therapy market, by country, 2018 - 2030 (USD Million)
Table 81 Middle East & Africa Iron Deficiency Anemia Therapy market, by Therapy Type, 2018 - 2030 (USD Million)
Table 82 Middle East & Africa Iron Deficiency Anemia Therapy market, by Age Group, 2018 - 2030 (USD Million)
Table 83 Middle East & Africa Iron Deficiency Anemia Therapy market, by End-User, 2018 - 2030 (USD Million)
Table 84 South Africa Iron Deficiency Anemia Therapy market, by Therapy Type, 2018 - 2030 (USD Million)
Table 85 South Africa Iron Deficiency Anemia Therapy market, by Age Group, 2018 - 2030 (USD Million)
Table 86 South Africa Iron Deficiency Anemia Therapy market, by End-User, 2018 - 2030 (USD Million)
Table 87 Saudi Arabia Iron Deficiency Anemia Therapy market, by Therapy Type, 2018 - 2030 (USD Million)
Table 88 Saudi Arabia Iron Deficiency Anemia Therapy market, by Age Group, 2018 - 2030 (USD Million)
Table 89 Saudi Arabia Iron Deficiency Anemia Therapy market, by End-User, 2018 - 2030 (USD Million)
Table 90 UAE Iron Deficiency Anemia Therapy market, by Therapy Type, 2018 - 2030 (USD Million)
Table 91 UAE Iron Deficiency Anemia Therapy market, by Age Group, 2018 - 2030 (USD Million)
Table 92 UAE Iron Deficiency Anemia Therapy market, by End-User, 2018 - 2030 (USD Million)
Table 93 Kuwait Iron Deficiency Anemia Therapy market, by Therapy Type, 2018 - 2030 (USD Million)
Table 94 Kuwait Iron Deficiency Anemia Therapy market, by Age Group, 2018 - 2030 (USD Million)
Table 95 Kuwait Iron Deficiency Anemia Therapy market, by End-User, 2018-2030, (USD Million)
List of Figures
Fig. 1 Market research process
Fig. 2 Information procurement
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 Value chain-based sizing & forecasting
Fig. 6 Market formulation & validation
Fig. 7 Iron deficiency anemia therapy, market segmentation
Fig. 8 Market snapshot, 2022
Fig. 9 Market Trends & Outlook
Fig. 10 Market driver relevance analysis (current & future impact)
Fig. 11 Market restraint relevance analysis (current & future impact)
Fig. 12 Market challenge relevance analysis (current & future impact)
Fig. 13 SWOT analysis
Fig. 14 Porter’s five forces analysis
Fig. 15 Global iron deficiency anemia therapy market: Therapy Type movement & market share analysis
Fig. 16 Global iron deficiency anemia therapy market, for oral iron therapy, 2018 - 2030 (USD Million)
Fig. 17 Global iron deficiency anemia therapy market, for parenteral iron therapy, 2018 - 2030 (USD Million)
Fig. 18 Global iron deficiency anemia therapy market, for red blood cell transfusion, 2018 - 2030 (USD Million)
Fig. 19 Global iron deficiency anemia therapy market, for other therapies, 2018 - 2030 (USD Million)
Fig. 20 Global iron deficiency anemia therapy market: Age group movement & market share analysis
Fig. 21 Global iron deficiency anemia therapy market, for adults, 2018 - 2030 (USD Million)
Fig. 22 Global iron deficiency anemia therapy market, for pediatric, 2018 - 2030 (USD Million)
Fig. 23 Global iron deficiency anemia therapy market, for geriatric, 2018 - 2030 (USD Million)
Fig. 24 Global iron deficiency anemia therapy market: End-user movement & market share analysis
Fig. 25 Global iron deficiency anemia therapy market, for clinics, 2018 - 2030 (USD Million)
Fig. 26 Global iron deficiency anemia therapy market, for hospitals, 2018 - 2030 (USD Million)
Fig. 27 Global iron deficiency anemia therapy market, for home healthcare, 2018 - 2030 (USD Million)
Fig. 28 Regional marketplace: key takeaways
Fig. 29 Regional outlook, 2022 & 2030
Fig. 30 Global iron deficiency anemia therapy market: region movement analysis
Fig. 31 North America iron deficiency anemia therapy market, 2018 - 2030 (USD Million)
Fig. 32 US key country dynamics
Fig. 33 US iron deficiency anemia therapy market, 2018 - 2030 (USD Million)
Fig. 34 Canada key country dynamics
Fig. 35 Canada iron deficiency anemia therapy market, 2018 - 2030 (USD Million)
Fig. 36 Europe iron deficiency anemia therapy market, 2018 - 2030 (USD Million)
Fig. 37 UK key country dynamics
Fig. 38 UK iron deficiency anemia therapy market, 2018 - 2030 (USD Million)
Fig. 39 Germany key country dynamics
Fig. 40 Germany iron deficiency anemia therapy market, 2018 - 2030 (USD Million)
Fig. 41 France key country dynamics
Fig. 42 France iron deficiency anemia therapy market, 2018 - 2030 (USD Million)
Fig. 43 Italy key country dynamics
Fig. 44 Italy iron deficiency anemia therapy market, 2018 - 2030 (USD Million)
Fig. 45 Spain key country dynamics
Fig. 46 Spain iron deficiency anemia therapy market, 2018 - 2030 (USD Million)
Fig. 47 Denmark key country dynamics
Fig. 48 Denmark iron deficiency anemia therapy market, 2018 - 2030 (USD Million)
Fig. 49 Sweden key country dynamics
Fig. 50 Sweden iron deficiency anemia therapy market, 2018 - 2030 (USD Million)
Fig. 51 Norway key country dynamics
Fig. 52 Norway iron deficiency anemia therapy market, 2018 - 2030 (USD Million)
Fig. 53 Asia Pacific iron deficiency anemia therapy market, 2018 - 2030 (USD Million)
Fig. 54 Japan key country dynamics
Fig. 55 Japan iron deficiency anemia therapy market, 2018 - 2030 (USD Million)
Fig. 56 China key country dynamics
Fig. 57 China iron deficiency anemia therapy market, 2018 - 2030 (USD Million)
Fig. 58 India key country dynamics
Fig. 59 India iron deficiency anemia therapy market, 2018 - 2030 (USD Million)
Fig. 60 Australia key country dynamics
Fig. 61 Australia iron deficiency anemia therapy market, 2018 - 2030 (USD Million)
Fig. 62 Thailand key country dynamics
Fig. 63 Thailand iron deficiency anemia therapy market, 2018 - 2030 (USD Million)
Fig. 64 South Korea key country dynamics
Fig. 65 South Korea iron deficiency anemia therapy market, 2018 - 2030 (USD Million)
Fig. 66 Latin America iron deficiency anemia therapy market, 2018 - 2030 (USD Million)
Fig. 67 Brazil key country dynamics
Fig. 68 Brazil iron deficiency anemia therapy market, 2018 - 2030 (USD Million)
Fig. 69 Mexico key country dynamics
Fig. 70 Mexico iron deficiency anemia therapy market, 2018 - 2030 (USD Million)
Fig. 71 Argentina key country dynamics
Fig. 72 Argentina iron deficiency anemia therapy market, 2018 - 2030 (USD Million)
Fig. 73 Middle East and Africa iron deficiency anemia therapy market, 2018 - 2030 (USD Million)
Fig. 74 South Africa key country dynamics
Fig. 75 South Africa iron deficiency anemia therapy market, 2018 - 2030 (USD Million)
Fig. 76 Saudi Arabia key country dynamics
Fig. 77 Saudi Arabia iron deficiency anemia therapy market, 2018 - 2030 (USD Million)
Fig. 78 UAE key country dynamics
Fig. 79 UAE iron deficiency anemia therapy market, 2018 - 2030 (USD Million)
Fig. 80 Kuwait key country dynamics
Fig. 81 Kuwait iron deficiency anemia therapy market, 2018 - 2030 (USD Million)
Fig. 82 Company market position analysis
Fig. 83 Company/competition categorization
Fig. 84 Strategy mapping

Companies Mentioned

  • Akebia Therapeutics, Inc.
  • Bayer AG
  • PHARMACOSMOS A/S
  • Sanofi
  • Johnson & Johnson Services, Inc.
  • CSL Vifor
  • AbbVie Inc. (Allergan)
  • Novartis AG
  • Teoxane
  • Zydus Group
  • GSK plc
  • AdvaCare Pharma
  • Apotex Inc.
  • Covis Pharma GmbH

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages120
PublishedSeptember 2023
Forecast Period2022 - 2030
Estimated Market Value ( USD ) in 2022 $ 4.49 Billion
Forecasted Market Value ( USD ) by 2030 $ 8.06 Billion
Compound Annual Growth Rate7.6%
Regions CoveredGlobal
No. of Companies Mentioned14

Related Topics

Related Reports

Iron Deficiency Anemia Therapy Market Analysis & Forecast to 2024-2034 - Product Image

Iron Deficiency Anemia Therapy Market Analysis & Forecast to 2024-2034

  • Report
  • 200 Pages
  • Global
From
Iron Deficiency Anemia Therapy Market Report: Trends, Forecast and Competitive Analysis to 2030 - Product Image

Iron Deficiency Anemia Therapy Market Report: Trends, Forecast and Competitive Analysis to 2030

  • Report
  • 150 Pages
  • Global
From
Iron Deficiency Anemia Therapy - Global Strategic Business Report - Product Image

Iron Deficiency Anemia Therapy - Global Strategic Business Report

  • Report
  • 192 Pages
  • Global
From
Iron Deficiency Anemia Therapy - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2021 - 2029 - Product Image

Iron Deficiency Anemia Therapy - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2021 - 2029

  • Report
  • 115 Pages
  • Global
From
Iron Deficiency Anemia Therapy Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2019-2029F - Product Image

Iron Deficiency Anemia Therapy Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2019-2029F

  • Report
  • 183 Pages
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.